ALKSAlkermes plc.同业对比
Alkermes plc. 与Pharmaceutical Preparations的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Pharmaceutical Preparations)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALKS本股 | $7.6B#8 | 118.6x#4 | 4.2x#1 | 5.1x#1 | -5.2%#10 | -34.2%#13 | 17.2%#2 | 13.4%#2 | 7.5%#2 | — | 57.8%#10 | — |
| AXSM | $11.0B#1 | — | 132.6x#12 | 17.3x#7 | 65.5%#6 | 36.2%#6 | -26.1%#6 | -219.9%#13 | — | — | 78.0%#8 | — |
| CYTK | $9.6B#2 | — | — | 108.9x#10 | 376.6%#3 | -33.2%#12 | -695.4%#12 | — | — | — | 39.7%#12 | — |
| ARWR | $9.5B#3 | — | 20.3x#9 | 11.4x#3 | 23258.2%#1 | 99.7%#2 | 11.9%#3 | -0.4%#4 | — | — | 112.4%#7 | — |
| PTGX | $9.2B#4 | 138.0x#5 | 10.9x#6 | 199.9x#12 | -89.4%#12 | -147.3%#15 | -343.6%#10 | -15.5%#8 | -36.7%#4 | — | 128.6%#6 | — |
| TGTX | $8.7B#5 | 20.7x#2 | 14.4x#7 | 14.1x#6 | 87.3%#5 | 1811.1%#1 | 20.0%#1 | 74.0%#1 | 14.2%#1 | — | 73.9%#9 | — |
| PRAX | $8.4B#6 | — | 6.3x#4 | — | -100.0%#13 | -65.6%#14 | — | -22.6%#9 | — | — | 568.8%#1 | — |
| SYRE | $8.1B#7 | 6.7x#1 | 7.3x#5 | — | — | 25.4%#7 | — | -14.1%#7 | — | — | 497.6%#2 | — |
| IONS | $7.5B#9 | — | 17.0x#8 | 7.9x#2 | 33.8%#9 | 16.0%#9 | -40.4%#8 | -86.7%#11 | -20.6%#3 | — | -26.9%#15 | — |
| GPCR | $7.4B#10 | — | 5.5x#2 | — | — | -15.2%#10 | — | -10.4%#6 | — | — | 49.4%#11 | — |
| RYTM | $6.7B#11 | — | 65.2x#11 | 35.4x#8 | 45.8%#8 | 24.6%#8 | -101.2%#9 | -0.2%#3 | -133.8%#5 | — | -1.0%#14 | — |
| ORKA | $6.3B#12 | — | 5.7x#3 | — | — | -25.9%#11 | — | -9.5%#5 | — | — | 474.1%#3 | — |
| MIRM | $6.1B#13 | — | — | 11.8x#4 | 54.7%#7 | 73.4%#4 | -4.2%#4 | — | — | — | 25.5%#13 | — |
| LQDA | $6.0B#15 | 48.0x#3 | 30.8x#10 | 38.0x#9 | 1031.2%#2 | 47.1%#5 | -32.5%#7 | -35.3%#10 | — | — | 172.3%#4 | — |
| TVTX | $6.0B#16 | — | 243.9x#13 | 12.2x#5 | 110.5%#4 | 92.1%#3 | -12.8%#5 | -104.2%#12 | — | — | 162.4%#5 | — |
| GOSS | $6.1B#14 | — | — | 124.9x#11 | -57.7%#11 | -201.4%#16 | -352.2%#11 | — | — | — | -95.0%#16 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-09-18。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议